Long
Updated

$CELZ LONG

365
Price target .25-.50

Market cap will explode. URA conference coming up at the end of may.
ED procedure already being adopted at big practices with top doctors.
Many more products in the pipeline with massive upside potential in multi billion dollar markets not to mention M&A in big pharma.
Will continue to add.
Note
Wish I had added even more. Hopefully fully debt free soon.
Massive upside here.
Note
Holding to massive spike, or till end of year
Note
Next up, .05
Note
TP: $15, Long hold.
I believe in stem cell research and the effect this company can have.
Note
Lots of great doctors will start to practice the ED procedure across the U.S

Very good time to own this stock.
Note
Keep er coming
Note
Consolidating. Lots of good buying pressure. This thing will jump up again in a matter of days. Expect that for the rest of 2018.
GLTA

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.